Stacie Calad-Thomson

Stacie Calad-Thomson is the current Chief Strategy Officer and Head of Drug Discovery at BioSymetrics. Prior to this, they were a Strategic Partnering Consultant at Helomics and the Founder and Consultant at Pharmaccelerate. Stacie has over 10 years of experience in the biotech and pharmaceutical industry and their work focuses on strategy, design, delivery, and partnerships.

Stacie has a Bachelor of Science in Biology from the University of Toronto and a Masters of Business Administration from Queen’s University.

Stacie Calad-Thomson has a PhD in Chemistry from UC Irvine and a BS in Chemistry from the University of California, Berkeley.

They are on a team with Victoria Catterson - VP, Research, Matthew Fusco - Chief Operating Officer, and Amanda Guisbond - VP, Marketing & Communications. Stacie Calad-Thomson reports to Anthony Iacovone, Co-founder & CEO.